Gaorong Capital Leads New Round In Chinese AI-Based Microbiome Drug Developer

Chinese artificial intelligence (AI)-based microbiome drug developer Xbiome has completed a new funding round led by the country’s venture capital firm Gaorong Capital and a Shenzhen-based investment company, according to a statement released on Monday.

China Money Network

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech


Register Now

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!


Already have an account or paid subscription? Log in

China Expert network

LEAVE A REPLY